BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37619559)

  • 21. Deep learning integrates histopathology and proteogenomics at a pan-cancer level.
    Wang JM; Hong R; Demicco EG; Tan J; Lazcano R; Moreira AL; Li Y; Calinawan A; Razavian N; Schraink T; Gillette MA; Omenn GS; An E; Rodriguez H; Tsirigos A; Ruggles KV; Ding L; Robles AI; Mani DR; Rodland KD; Lazar AJ; Liu W; Fenyö D;
    Cell Rep Med; 2023 Sep; 4(9):101173. PubMed ID: 37582371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
    Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
    Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ProNetView-ccRCC: A Web-Based Portal to Interactively Explore Clear Cell Renal Cell Carcinoma Proteogenomics Networks.
    Kalayci S; Petralia F; Wang P; Gümüş ZH
    Proteomics; 2020 Nov; 20(21-22):e2000043. PubMed ID: 32358997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.
    Geffen Y; Anand S; Akiyama Y; Yaron TM; Song Y; Johnson JL; Govindan A; Babur Ö; Li Y; Huntsman E; Wang LB; Birger C; Heiman DI; Zhang Q; Miller M; Maruvka YE; Haradhvala NJ; Calinawan A; Belkin S; Kerelsky A; Clauser KR; Krug K; Satpathy S; Payne SH; Mani DR; Gillette MA; Dhanasekaran SM; Thiagarajan M; Mesri M; Rodriguez H; Robles AI; Carr SA; Lazar AJ; Aguet F; Cantley LC; Ding L; Getz G;
    Cell; 2023 Aug; 186(18):3945-3967.e26. PubMed ID: 37582358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
    Vasaikar SV; Straub P; Wang J; Zhang B
    Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
    Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
    Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
    Wen B; Li K; Zhang Y; Zhang B
    Nat Commun; 2020 Apr; 11(1):1759. PubMed ID: 32273506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of recent advances in proteogenomics.
    Locard-Paulet M; Pible O; Gonzalez de Peredo A; Alpha-Bazin B; Almunia C; Burlet-Schiltz O; Armengaud J
    Expert Rev Proteomics; 2016; 13(2):185-99. PubMed ID: 26654119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tool for integrating genetic and mass spectrometry-based peptide data: Proteogenomics Viewer: PV: A genome browser-like tool, which includes MS data visualization and peptide identification parameters.
    Kroll JE; da Silva VL; de Souza SJ; de Souza GA
    Bioessays; 2017 Jul; 39(7):. PubMed ID: 28582591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Proteogenomic Analysis Reveals Multiple Peptide Mutations and Complex Immunoglobulin Peptides in Colon Cancer.
    Woo S; Cha SW; Bonissone S; Na S; Tabb DL; Pevzner PA; Bafna V
    J Proteome Res; 2015 Sep; 14(9):3555-67. PubMed ID: 26139413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational Analysis of Phosphoproteomics Data in Multi-Omics Cancer Studies.
    Mantini G; Pham TV; Piersma SR; Jimenez CR
    Proteomics; 2021 Feb; 21(3-4):e1900312. PubMed ID: 32875713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
    Krug K; Jaehnig EJ; Satpathy S; Blumenberg L; Karpova A; Anurag M; Miles G; Mertins P; Geffen Y; Tang LC; Heiman DI; Cao S; Maruvka YE; Lei JT; Huang C; Kothadia RB; Colaprico A; Birger C; Wang J; Dou Y; Wen B; Shi Z; Liao Y; Wiznerowicz M; Wyczalkowski MA; Chen XS; Kennedy JJ; Paulovich AG; Thiagarajan M; Kinsinger CR; Hiltke T; Boja ES; Mesri M; Robles AI; Rodriguez H; Westbrook TF; Ding L; Getz G; Clauser KR; Fenyö D; Ruggles KV; Zhang B; Mani DR; Carr SA; Ellis MJ; Gillette MA;
    Cell; 2020 Nov; 183(5):1436-1456.e31. PubMed ID: 33212010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moonshot Objectives: Catalyze New Scientific Breakthroughs-Proteogenomics.
    Rodland KD; Piehowski P; Smith RD
    Cancer J; 2018; 24(3):121-125. PubMed ID: 29794536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMAP is a pipeline for sample matching in proteogenomics.
    Li L; Niu M; Erickson A; Luo J; Rowbotham K; Guo K; Huang H; Li Y; Jiang Y; Hur J; Liu C; Peng J; Wang X
    Nat Commun; 2022 Feb; 13(1):744. PubMed ID: 35136070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
    Dimitrakopoulos L; Prassas I; Diamandis EP; Charames GS
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):414-432. PubMed ID: 29025326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Precision oncology from a proteogenomics perspective].
    Huang Y; Wu S; Shu K; Zhu Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3616-3627. PubMed ID: 36305397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Proteogenomics with Peptide
    Blank-Landeshammer B; Teichert I; Märker R; Nowrousian M; Kück U; Sickmann A
    mBio; 2019 Oct; 10(5):. PubMed ID: 31615963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
    Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
    Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells.
    Li Y; Wang X; Cho JH; Shaw TI; Wu Z; Bai B; Wang H; Zhou S; Beach TG; Wu G; Zhang J; Peng J
    J Proteome Res; 2016 Jul; 15(7):2309-20. PubMed ID: 27225868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.